Search

Search Constraints

You searched for: Author/Creator Ny, Lars

Search Results

1. A Population Based Comparison of the AJCC 7th And AJCC 8th Editions for Patients Diagnosed With Stage III Cutaneous Malignant Melanoma in Sweden. Issue 2 (February 2020)

4. Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy. (2nd September 2022)

5. Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis. Issue 7 (2nd July 2021)

6. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016)

8. Nivoilp Trial - A Phase Ib/II Randomized Double-Blind Placebo-Controlled Trial Evaluating the Effect of Nivolumab for Patients with In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion. Issue 2 (February 2020)

9. Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination. Issue 1 (1st January 2023)

10. Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial. (3rd July 2022)